House Appropriations Committee approves fiscal 2018 Labor-HHS spending bill

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The House Appropriations Committee marked up the fiscal 2018 Labor-HHS funding bill with a vote of 28-22 on July 19.

The bill includes a $1.1 billion increase for NIH, a $82 million funding boost for the NCI, and preserves the individual programs and current funding levels for the Centers for Disease Control and Prevention cancer screening and early detection programs. This version of the bill eliminates funding for the Affordable Care Act and the Family Planning (Title X) Program (The Cancer Letter, July 14).

“United for Medical Research applauds the increase to the budget for NIH contained in the Labor, Health and Human Services, and Education funding bill approved by the House Appropriations Committee yesterday,” UMR President Lizbet Boroughs said in a statement. “We are deeply appreciative of Subcommittee Chairman Tom Cole’s unwavering support for boosting funding for medical research.

“We also want to thank Ranking Member Rosa DeLauro and full Committee Chairman Rodney Frelinghuysen and Ranking Member Nita Lowey for making funding for medical research a high priority in this bill. We look forward to working with the Senate on its Labor-HHS funding bill and with the full Congress to ensure a 2018 budget solution that enables increased funding for the NIH and the medical research initiatives called for by the 21st Century Cures Act.”

YOU MAY BE INTERESTED IN

FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA. 
In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login